AfterNext HealthTech Acquisition Corp.

AfterNext HealthTech Acquisition Corp.

AFTR
AfterNext HealthTech Acquisition Corp.US flagNew York Stock Exchange
10.41
USD
+0.00
- -
325.31MMarket Cap
AfterNext HealthTech Acquisition Corp.
AFTR
(New York Stock Exchange)

Recent

price

10.41

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
AfterNext HealthTech Acquisition Corp. (AFTR) operates as a blank check company, or special purpose acquisition company (SPAC), focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or assets in the healthcare technology sector; it currently conducts no significant operations and holds cash in trust pending a de-SPAC transaction. Incorporated in 2021 as a Cayman Islands exempted company and headquartered at 301 Commerce St., Suite 3300, Fort Worth, Texas, the company targets innovative HealthTech firms aligned with the expertise of its leadership team, including Chairman and CEO Halsey Wise and President Anthony Colaluca, in partnership with TPG; its geographic focus spans global opportunities with emphasis on U.S.-based targets serving healthcare providers, payers and technology integrators. AfterNext raised $250 million in its August 2021 initial public offering, priced at $10 per unit with Goldman Sachs, Deutsche Bank Securities and BofA Securities as joint bookrunners, granting underwriters a 45-day overallotment option for an additional 3.75 million units; as of late 2025, its Class A shares trade around $10.41 with a market capitalization of approximately $325 million, but it has not announced a merger target or completed a business combination within its original 24-month tenor, prompting ongoing evaluations for extensions amid a competitive SPAC landscape.